GRX GRX
Company Profile ↓Company Overview
GRX (GRX) is a publicly traded company listed on with a market capitalization of $149.90M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Maintains a net profit margin of 77.3%.
Carries low leverage with a debt-to-equity ratio of 0.01.
Recent Developments
- Dec 2025 Revenue of $2.97M (+765.3% YoY); net profit $2.29M.
- Trailing 12 Months Year-on-year growth — revenue +765.3%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | - |
| 1 Year: | 765.31% |
Stock Price Performance
| 1 Year: | +15.10% |
| 6 Months: | +13.12% |
| 3 Months: | +5.05% |
| 1 Month: | +1.32% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)60.42 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Excellent profit margin of 77.3%.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Trading at a high P/E of 66.4.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Revenue | -46.71M | 1.24M | 342.91K | 2.97M |
| Cost of Revenue | - | - | - | - |
| Gross Profit | - | - | - | - |
| Operating Expenses | 727.90K | 817.28K | 627.91K | 672.57K |
| Operating Income | - | - | - | - |
| EBITDA | - | - | - | - |
| Interest Expense | 3.18M | 2.77M | 2.92M | 2.45M |
| Pretax Income | -47.44M | 422.80K | -285.00K | 2.29M |
| Tax Provision | - | - | - | - |
| Net Income | -47.44M | 422.80K | -285.00K | 2.29M |
| Diluted EPS | -2.76 | 0.08 | 0.02 | 0.15 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 248.70M | 239.04M | 225.71M | 241.89M |
| Current Assets | - | - | - | - | - |
| Cash & Equivalents | - | 50.49K | 2.37K | - | 17.98K |
| Inventory | - | - | - | - | - |
| Receivables | - | 6.63M | 772.25K | 423.69K | 393.37K |
| Total Liabilities | - | 44.04M | 54.23M | 54.85M | 83.38M |
| Current Liabilities | - | - | - | - | - |
| Long Term Debt | - | - | - | - | - |
| Total Debt | 68.50K | - | 384 | 10.10K | - |
| Total Equity | - | 204.65M | 184.81M | 170.86M | 158.51M |
| Shares Outstanding | - | 17.04M | 15.96M | 15.52M | 15.05M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 58.11M | 6.61M | 13.11M | -2.09M |
| Investing Cash Flow | - | - | - | - | - |
| Financing Cash Flow | - | -58.06M | -6.66M | -13.11M | 2.11M |
| Capital Expenditure | - | - | - | - | - |
| Free Cash Flow | - | 58.11M | 6.61M | 13.11M | -2.09M |
| Net Change in Cash | - | 50.49K | -48.50K | -1.98K | 17.98K |
Ratios (Annual)
Figures in %.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Gross Margin % | - | - | - | - |
| Operating Margin % | - | - | - | - |
| Net Margin % | 101.6% | 34.1% | -83.1% | 77.3% |
| ROE % | -23.2% | 0.2% | -0.2% | 1.4% |
| ROCE % | - | - | - | - |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for GRX
Saba Capital Management buys $1,976 in Gabelli Healthcare shares - Investing.com
<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxPQ0NCM3JtQThEYkR2eGtDc0hwdmNKT0xEeTROZUR6dVMtbHFmRGNIalNqaDJrdmtldExpZVpkRl9aUFRWVmgyMDRteGRoN2pwRVhFN3paN1lBcGdubTdhZ01qbks4ak8wMG54YmNoNl9pbW5LaVNVeTBwSFZ0SU9fM0hCRVRLc0dsWGU1Zl…
Precision Trading with The Gabelli Healthcare & Wellness Trust Of Beneficial Interest (GRX) Risk Zones - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMiigJBVV95cUxNWFZsbndYU1pUOVFzeHViaVJDcDhEUXo2dHVwa2RYWk1hcEd6UGdJNVQ5Y1pQdTM5SFk1SjllZ0VSM2JGWG5WSGV2ZW9EajluUTB0STJza1pmeTljU2FsVE43VDY0eGRNeklCYVNZWGltblNaUnBnWDZ3akJWa2wzY3hwWk1VNFpSZ3BPM2…
Saba Capital Management, L.P. Adds to Gabelli Healthcare & Welln - GuruFocus
<a href="https://news.google.com/rss/articles/CBMi5AFBVV95cUxPdWZQZTlzb2o4TlNuWGQ4MVJscnNZdlpPSzAyZ3ptOUVZZTBwVGwwMWQxUHFvN3p4OG1Jb2VpM3huSEI3b3pNU3NWbjZabWFPZ3V0MzIzT25UVERIc1VuMGVkc1lyNG5JcS1BWnBfY0lSV0ExLUpfUFJzUmNFOG5XOUVrb1k1WFpYaTZISm…
At $9.43 a share, Saba buys 2,955 shares in Gabelli Healthcare & WellnessRx Trust (GRX). - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiyAFBVV95cUxPQ0Z2ZFJ5eW9qOEUwVzh2X1YzdUtJSFEzS2NfM1lUeDROeXhoRkoxb3B5UXJMNDM0RFNodlhwR0xUa1RMZkVUMEtpWmZMQ1RZZU5MUUo1UnhtN3RhcFc3V2Y4ZktKdDNMWUp3NG16d2JYcmFiRWs3c2R1dl8yUnFDa0U4WnFYNTZWSjNxQW…
I Rode the New Shimano Di2 Groupset for a Year. Here Is Why It Is the Best Gravel Drivetrain on the Market. - Outside Magazine
<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxNV3d5bmhTS0d1anp4ZFUyZFl3TWtrVXJLZEpSSnVyU3Z2Tl9xa29MNXJLcWFfdUQ3Ukk0dHFTWU9Ua2VNbERVdnA2RkhvalBLdkxsX2xtZW9yWC1MaDNkNkg1a2Rzei1USnhkdTA0UmQ3NU5jU1Y2VFBkTWtMeThPOGxqQUY5djJvbzVZYz…
Saba Capital buys $4,940 in Gabelli Healthcare & WellnessRx trust By Investing.com - Investing.com South Africa
<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxQU2liQXdRQVg3S01TM1pwNFFuMnBHR2NLeTRMNkhKQzB0aUlISXVXTHhpRnRJWmlXbzFIaWl2Rmk1Z2UxaENzcTVMTmJ0Q1E4UmhtVklCbVV1YXNYUm5ZNUtaRk9TYkg5QjBYZU9DSFpzRm4wQlgtMG1kSTg3VDZfZ1NfZUZ0ZWhTV2JxNl…
GRX — Frequently Asked Questions
What is the current share price of GRX?
As of 2026-10-23 16:27 PDT, GRX trades at $9.96 on NASDAQ/NYSE. Its 52-week range is $8.53 to $10.09.
What is the market capitalisation of GRX?
GRX has a market capitalisation of $149.90M on NASDAQ/NYSE.
What is the P/E ratio of GRX?
GRX trades at a trailing price-to-earnings (P/E) ratio of 66.40. Its price-to-book (P/B) ratio is 0.95.
What is the return on equity (ROE) of GRX?
GRX has a return on equity (ROE) of 1.45%.
Is GRX a good stock to buy?
This page provides a data-driven analysis of GRX, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.